Sign in
4

Changes in Ownership

Atea Pharmaceuticals, Inc. Filed Acc 0000899243-22-023496

Options or other derivatives

  • Director acquired 61,264 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Polsky Bruce Director 2022-06-17 Grant or award · Stock Option (Right to Buy) +61,264 61,264 D: show line 1 in the form
Loading xslF345X03/doc4.xml…